Evaluation of anticancer activities of benzo[c]phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line

Anticancer Research

Volumn 31, Issue 9, 2011, Pages 2841-2846

  Tsukamoto, Hikari ^a   Kondo, Seiji ^a   Mukudai, Yoshiki ^a   Nagumo, Tatsuhito ^a   Yasuda, Arisa ^a   Kurihara, Yuji ^a   Kamatani, Takaaki ^a   Shintani, Satoru ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Anticancer therapeutic agents; Benzo c phenanthridine alkaloids; Oral squamous cell carcinoma; Sanguinarine

Indexed keywords

CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; SANGUINARINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL ANCHORAGE; CELL DEATH; CELL GROWTH; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BENZOPHENANTHRIDINES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; HUMANS; ISOQUINOLINES; MOUTH NEOPLASMS;

EID: 80051655844     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Clayman GL, Ebihara S, Terada M, Mukai K and Goepfert H: Report of the Tenth International Symposium of the Foundation for Promotion of Cancer Research: Basic and clinical research in head and neck cancer. Jap J Clin Oncol 27: 361-368, 1997. (Pubitemid 127520831)
2. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, Geara FB, Klotch DW, Goepfert H and Peters LJ: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 571-578, 2001.
3. No authors listed: Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the head and neck contracts program. Cancer 60: 301-311, 1987.
4. Ilaria DS, Giuseppina R, Gian FZ, Daniele T, Maria GP, Marco M, Cristiano F, Giovanni S and Daniela G: Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochemi Pharmacol 78: 1374-1381, 2009.
5. Mukherjee AK, Basu S, Sarkar N and Ghosh AC: Advances in cancer therapy with plant based natural products. Curr Med Chem 8: 1467-1486, 2001. (Pubitemid 32894010)
6. Wang BH, Lu ZX and Polya GM: Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids. Planta Med 63: 494-498, 1997. (Pubitemid 28035441)
7. Herbert JM, Augereau JM, Gleye J and Maffrand JP: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biophys Res Commun 172: 993-999, 1990.
8. Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa K and Yamashita S: Induction of thyroid cancer cell apoptosis by a novel nuclear factor KB inhibitor, dehydroxymethylepoxyquinomicin. Clin Cancer Res 10: 6821-6829, 2004. (Pubitemid 39383030)
9. Hyunjin P, Eric B, Helena S, Kim G, Sabrina B, Richard B, Joel S and Nathalie F: Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochem Biophy Res Comm 399: 446-451, 2010.
10. Aparajita D, Mukherjee A and Chakrabarti J: Sanguinarine: an evaluation of in vivo cytogenetic activity. Mut Res 563: 81-87, 2004. (Pubitemid 39504761)
11. Nihal A, Sanjay G, Mirza MH, Kaisa MH and Husan M: Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 6: 1524-1528, 2000.
12. Vaqar MA, Moammir HA, Hasan M and Nihal A: Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin Cancer Res 9: 3176-3182, 2003.
13. Janq BC, Park JG, Song DK, Baek WK, Yoo SK, Junq KH, Park Gy, Lee TY and Suh SI: Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicol in vitro 23: 281-287, 2009.
14. Yung HC, Woo YC, Su HH, Sung OK, Gi-YK, Won HL and Young HY: Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem-Biol Interac 179: 185-191, 2009.
15. Choi WY, Kim GY, Lee WH and Choi YH: Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy 54: 279-287, 2008.
16. Ahsan H, Reagan-SS, Breur J and Ahmad N: Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett 249: 198-208, 2007. (Pubitemid 46452928)
17. Matkar SS, Wrischnik LA and Hellmann-BU: Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chem Biol Interact 172: 63-71, 2008.
18. Matkar SS, Wrischnik LA and Hellmann-BU: Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chem Biol Interact 172: 63-71, 2008.
19. Nagumo T, Takaoka S, Yoshiba S, Ohashi M, Shirota T, Hatori M, Isobe T, T achikawa T and Shintani S: Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous-cell carcinoma cell lines in vitro and in vivo. Oral Oncol 45: 766-770, 2009.
20. Arisa Y, Seiji K, Tatsuhito N, Hikari T, Yoshiki M, Kazuo U and Satoru S: Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo. Oral Oncol 47: 334-339, 2011.
21. Zheng ZW, Song SZ, Wu YL, Lian LH, Wan Y and Nan JX: Betulinic acid prevention of D-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms. J Pharm Pharmacol 63: 572-578, 2011.
22. Xu ZW, Wanq FM, Gao MJ, Chen XY, Hu WL and Xu RC: Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting. Biol Pharm Bull 33: 743-775, 2010.